Expand MBX Menu
MBX MENU

MBX Latest Press Releases

-- April 3, 2026 --

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- March 12, 2026 --

MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights Globe Newswire 8:00 AM

-- March 10, 2026 --

MBX Biosciences Appoints Karen Basbaum as Chief Business Officer Globe Newswire 8:00 AM

-- March 9, 2026 --

CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism Globe Newswire 10:21 AM
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism Globe Newswire 8:00 AM

-- February 23, 2026 --

MBX Biosciences to Participate in Upcoming March Investor Conferences Globe Newswire 8:00 AM

-- February 11, 2026 --

MBX Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- January 22, 2026 --

MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair Globe Newswire 8:00 AM

-- January 11, 2026 --

MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:00 PM

-- December 15, 2025 --

MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 Globe Newswire 8:00 AM

-- November 18, 2025 --

MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes